Validation of the EASL 2017 HBV Clinical Practice Guidelines criteria for switching patients long-term treated with Tenofovir Difumarate to Entecavir or Tenofovir Alafenamide in a real-life setting. Issue 1 (February 2018) - Loglio, A.; Grossi, G.; Soffredini, R.; Borghi, M.; Facchetti, F.; Galmozzi, E.; Perbellini, R.; Lunghi, G.; Lampertico, P.